Search: WFRF:(van der Schee M. P.) >
Rationale and desig...
Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium
-
Farzan, N (author)
-
Vijverberg, SJ (author)
-
Andiappan, AK (author)
-
show more...
-
Arianto, L (author)
-
Berce, V (author)
-
Blanca-Lopez, N (author)
-
Bisgaard, H (author)
-
Bonnelykke, K (author)
-
Burchard, EG (author)
-
Campo, P (author)
-
Canino, G (author)
-
Carleton, B (author)
-
Celedon, JC (author)
-
Chew, FT (author)
-
Chiang, WC (author)
-
Cloutier, MM (author)
-
Daley, D (author)
-
Den Dekker, HT (author)
-
Dijk, NF (author)
-
Duijts, L (author)
-
Flores, C (author)
-
Forno, E (author)
-
Hawcutt, DB (author)
-
Hernandez-Pacheco, N (author)
-
de Jongste, JC (author)
-
Kabesch, M (author)
-
Koppelman, GH (author)
-
Manolopoulos, VG (author)
-
- Melen, E (author)
- Karolinska Institutet
-
Mukhopadhyay, S (author)
-
- Nilsson, S (author)
- Karolinska Institutet
-
Palmer, CN (author)
-
Pino-Yanes, M (author)
-
Pirmohamed, M (author)
-
Potocnki, U (author)
-
Raaijmakers, JA (author)
-
Repnik, K (author)
-
Schieck, M (author)
-
Sio, YY (author)
-
Smyth, RL (author)
-
Szalai, C (author)
-
Tantisira, KG (author)
-
Turner, S (author)
-
van der Schee, MP (author)
-
Verhamme, KM (author)
-
Maitland-van der Zee, AH (author)
-
show less...
-
(creator_code:org_t)
- Future Medicine Ltd, 2017
- 2017
- English.
-
In: Pharmacogenomics. - : Future Medicine Ltd. - 1744-8042 .- 1462-2416. ; 18:10, s. 931-943
- Related links:
-
https://europepmc.or...
-
show more...
-
http://kipublication...
-
https://doi.org/10.2...
-
show less...
Abstract
Subject headings
Close
- Aim: International collaboration is needed to enable large-scale pharmacogenomics studies in childhood asthma. Here, we describe the design of the Pharmacogenomics in Childhood Asthma (PiCA) consortium. Materials & methods: Investigators of each study participating in PiCA provided data on the study characteristics by answering an online questionnaire. Results: A total of 21 studies, including 14,227 children/young persons (58% male), from 12 different countries are currently enrolled in the PiCA consortium. Fifty six percent of the patients are Caucasians. In total, 7619 were inhaled corticosteroid users. Among patients from 13 studies with available data on asthma exacerbations, a third reported exacerbations despite inhaled corticosteroid use. In the future pharmacogenomics studies within the consortium, the pharmacogenomics analyses will be performed separately in each center and the results will be meta-analyzed. Conclusion: PiCA is a valuable platform to perform pharmacogenetics studies within a multiethnic pediatric asthma population.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Farzan, N
-
Vijverberg, SJ
-
Andiappan, AK
-
Arianto, L
-
Berce, V
-
Blanca-Lopez, N
-
show more...
-
Bisgaard, H
-
Bonnelykke, K
-
Burchard, EG
-
Campo, P
-
Canino, G
-
Carleton, B
-
Celedon, JC
-
Chew, FT
-
Chiang, WC
-
Cloutier, MM
-
Daley, D
-
Den Dekker, HT
-
Dijk, NF
-
Duijts, L
-
Flores, C
-
Forno, E
-
Hawcutt, DB
-
Hernandez-Pachec ...
-
de Jongste, JC
-
Kabesch, M
-
Koppelman, GH
-
Manolopoulos, VG
-
Melen, E
-
Mukhopadhyay, S
-
Nilsson, S
-
Palmer, CN
-
Pino-Yanes, M
-
Pirmohamed, M
-
Potocnki, U
-
Raaijmakers, JA
-
Repnik, K
-
Schieck, M
-
Sio, YY
-
Smyth, RL
-
Szalai, C
-
Tantisira, KG
-
Turner, S
-
van der Schee, M ...
-
Verhamme, KM
-
Maitland-van der ...
-
show less...
- Articles in the publication
-
Pharmacogenomics
- By the university
-
Karolinska Institutet